PDS Biotechnology Corp (NAS:PDSB)
$ 3.51 -0.32 (-8.36%) Market Cap: 128.74 Mil Enterprise Value: 96.03 Mil PE Ratio: 0 PB Ratio: 4.44 GF Score: 35/100

Q2 2023 PDS Biotechnology Corp Earnings Call Transcript

Aug 14, 2023 / 12:00PM GMT
Release Date Price: $5.33 (+9.90%)
Operator

Hello, and welcome to the PDS Biotechnologies Second Quarter 2023 Earnings Call and Webcast.

(Operator Instructions)

A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to your host, Gabby DeGravina, Investor Relations. Please go ahead, Gabby.

Gabrielle DeGravina

Good morning, and welcome to PDS Biotechnologies Second Quarter 2023 Earnings Conference Call and Audio Webcast.

On the call from the company are Dr. Frank Bedu-Addo, Chief Executive Officer; Matt Hill, Chief Financial Officer; and Dr. Lauren V. Wood, Chief Medical Officer.

Earlier this morning, PDS Biotech issued a press release announcing financial results for the quarter ended June 30, 2023. We encourage everyone to read the press release as well as PDS Biotech's report on Form 10-Q, which will be filed with the SEC shortly.

The company's press release is available on the PDS website at pdsbiotech.com. In addition, this conference call is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot